Global HealthTech Unicorns

The Complete List of Global HealthTech Unicorns

Black Unicorn made out of triangles

Global HealthTech Unicorns

A unicorn startup or unicorn company is a private company with a valuation over $1 billion USD. Unicorns are ‘startups’, i.e they do not include post-exit, acquired or listed companies, nor do they include ‘mature’ incumbents.

As of 2 November 2021, there are 76 HealthTech Unicorns around the world who are now collectively valued at $154B+.

Elemy, Dental Monitoring, and Truepill joined the list in Oct 2021.

PharmEasy, Prime Medicine, Cerebral, and SonderMind joined the list in June – July 2021.

Roivant Sciences left the list in May 2021 via IPO.

Capsule, KRY, Caris Life Sciences, Collective Health and Noom joined the list in Apr – May 2021.

Aledade, EQRx, Innovaccer, ATAI Life Sciences, Brii BioSciences, Evidation Health, Ginger, Komodo Health, Radiology Partners, Rightway, Unite Us, DispatchHealth, Pear Therapeutics, and Insitro joined the list in Jan – Mar 2021.

Recursion Pharmaceuticals left the list in April 2021 via IPO.

Oscar Health left the list in March 2021 via IPO.

Sema4 was acquired by Casdin Capital and Corvex Management (SPAC) in February 2021.

23andMe was acquired by Virgin Galactic Acquisition Corporation (SPAC) in February 2021.

Tempus was acquired by PNC Bank in January 2021.

Clover Health left the list in January 2021 via IPO.

CompanyCountryLast Round DateLast Round TypeValuation
SamumedUnited StatesApr 2019Series C$12.4B
Caris Life SciencesUnited StatesMay 2021$830M PE Round$7.83B
WeDoctor (GuaHao)ChinaMay 2018$500M Series F$7B
Hinge HealthUnited StatesOct 2021$600M Series E$6.2B
Cityblock HealthUnited StatesSep 2021$400M Series D$5.7B
United Imaging HealthcareChinaSep 2017$500M Series A$5.1B
Outcome HealthUnited StatesMar 2021$500M Series D$5B
RoUnited StatesMar 2021$500M Series D$5B
Ginkgo BioWorksUnited StatesMay 2020$70M Series E$4.2B
Radiology PartnersUnited StatesMar 2021$12.6M Venture Round$4B
Devoted HealthUnited StatesMar 2020$450M Series C$3.8B
Intarcia TherapeuticsUnited StatesAug 2019Undisclosed$3.8B
NoomUnited StatesMay 2021$540M Series F$3.7B
OttobockGermanyDec 2019Debt$3.5B
Komodo HealthUnited StatesMar 2021$220M Series E$3.3B
GrailUnited StatesMay 2020$390M Series D$3.2B
InsitroUnited StatesMar 2021$400M Series C$2.4B
Lyra HealthUnited StatesMay 2021$200M Series F$2.3B
BenevolentAIUnited KingdomSep 2019$90M Series C$2.1B
KRYSwedenApr 2021$319M Series D$2B
ATAI Life SciencesGermanyMar 2021$157M Series D$2B
Oxford Nanopore TechnologiesUnited KingdomMay 2020$59.2M Series G$2B
Babylon HealthUnited KingdomAug 2019$550M Series C$2B
AledadeUnited StatesJan 2021$100M Series D$1.9B
Virta HealthUnited StatesApr 2021$133M Series D$1.9B
PharmEasyIndiaJuly 2021$500M Series F$1.8B
ZocdocUnited StatesAug 2015$130M Series D$1.8B
DispatchHealthUnited StatesMar 2021$200M Series D$1.7B
Unite UsUnited StatesMar 2021$150M Series C$1.7B
TruepillUnited StatesOct 2021$142M Series D$1.6B
Pear TherapeuticsUnited StatesMarch 2021$20M Series D$1.6B
VerilyUnited StatesJan 2019$1B PE Round$1.6B
Collective HealthUnited StatesMay 2021$280M Series F$1.5B
K HealthUnited StatesJan 2021$132M Series E$1.5B
ColorUnited StatesJan 2021$167M Series D$1.5B
StravaUnited StatesNov 2020$110M Series F$1.5B
InsightecIsraelMar 2020$150M Series F$1.5B
HeartFlowUnited StatesJun 2019$65M Series E$1.5B
Brii BiosciencesUnited StatesMar 2021$155M Series C$1.45B
AlzheonUnited StatesSep 2020$2.4M Venture Round$1.31B
InnovaccerUnited StatesFeb 2021$105M Series D$1.3B
MedlinkerChinaJul 2018$146.8M Series D$1.25B
CerebralUnited StatesJune 2021$127M Series B$1.23B
EQRxUnited StatesJan 2021$500M Series B$1.23B
ElemyUnited StatesOct 2021$219M Series B$1.2B
Prime MedicineUnited StatesJuly 2021$200M Series B$1.2B
Modern HealthUnited StatesFeb 2021$74M Series D $1.2B
Lyell ImmunopharmaUnited StatesMar 2020$493M Series C$1.2B
GingerUnited StatesMar 2021$100M Series E$1.1B
RightwayUnited StatesMar 2021$100M Series C$1.1B
DoctolibFranceMar 2019$170M Series E$1.1B
Dental MonitoringFranceOct 2021$150M PE Round$1B
SonderMindUnited StatesJuly 2021$150M Series C$1B
LetsGetCheckedIrelandJune 2021$150M Series D$1B
Thirty MadisonUnited StatesJune 2021$140M Series C$1B
CapsuleUnited StatesApr 2021$300M Series D$1B
Evidation HealthUnited StatesMar 2021$153M Series E$1B
Bright HealthUnited StatesSep 2020$500M Series E$1B
ZwiftUnited StatesSep 2020$450M Series C$1B
VillageMDUnited StatesJul 2020$275M VC Round$1B
Miaoshou DoctorChinaJun 2020$84.7M Series D$1B
Orca BioUnited StatesJun 2020$192M Series D$1B
KeepChinaMay 2020$80M Series E$1B
Alto PharmacyUnited StatesJan 2020$250M Series D$1B
CMR SurgicalUnited KingdomSep 2019$240M Series C$1B
CalmUnited StatesJul 2019$27M Series B$1B
GympassUnited StatesJun 2019$300M Series D$1B
AprogenSouth KoreaMay 2019$1B
LinkDocChinaJul 2018$151M Series D$1B
iCarbonXChinaJun 2018$141.77M Series A$1B
DXYChinaApr 2018$100M Series D$1B
OrCamIsraelFeb 2018$30.4M VC Round$1B
PointClickCareCanadaFeb 2018$146M Series D$1B
Rani TherapeuticsUnited StatesFeb 2018$53M$1B
MindmazeSwitzerlandSep 2017$1B
Modernizing MedicineSwitzerlandMay 2017$231M PE Round$1B

 

Where is this data coming from?

HolonIQ is the world's leading impact intelligence platform. We support governments, institutions, firms and investors, with data insights to power decisions that matter. If you are not already a client, request a demo to learn more about our platform.
Complex abstract graph background

Related Research

The Complete List of Global EdTech Unicorns

27 January 2022. 

The Complete List of Global EdTech Unicorns

Global Climate Tech Venture Capital Report – Full Year 2021

4 January 2022. 

$37B Global Venture Capital was invested into Climate Tech in 2021.

The Complete List of Global Climate Tech Unicorns

3 January 2022. 

The Complete List of Global Climate Tech Unicorns

Global EdTech Venture Capital Report – Full Year 2021

3 January 2022. 

$20.8B of EdTech Venture Capital Investment in 2021 through more than 1,500 Funding Rounds.

Share